Patent Application Titled "Solid State Forms Of Reproxalap" Published Online (USPTO 20240425458).

A patent application titled "Solid State Forms Of Reproxalap" has been published online, detailing the development of Reproxalap, a small molecule inhibitor for various eye conditions. The application discusses the discovery of new salts and solid state forms of Reproxalap, which may improve formulation, processing, and stability of pharmaceutical products. These new forms of Reproxalap salts could be used in medicaments for treating dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjogren-Larsson Syndrome. [Extracted from the article]